Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril

Details

Serval ID
serval:BIB_41FF412A119D
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril
Journal
Acta Cardiologica
Author(s)
Brunner  H. R., Nussberger  J., Waeber  B.
ISSN
0001-5385 (Print)
Publication state
Published
Issued date
1986
Volume
41
Number
5
Pages
341-50
Notes
Journal Article
Review
Abstract
Enalapril is a new angiotensin converting enzyme inhibitor which, when absorbed by the digestive tract, is converted to enalaprilat. This metabolite is, in fact, the active form of enalapril. Its duration of action is sufficiently long so that enalapril can be administered in a single daily dose. Enalapril has been proved to be a highly effective therapeutic agent which is well tolerated by patients with arterial hypertension or severe congestive heart failure.
Keywords
*Angiotensin-Converting Enzyme Inhibitors Enalapril/*pharmacology/therapeutic use Heart Failure, Congestive/drug therapy Humans Hypertension/drug therapy
Pubmed
Web of science
Create date
05/03/2008 17:41
Last modification date
20/08/2019 14:43
Usage data